Pfizer scraps daily weight loss pill after liver injury in one patient

Pfizer has ended development of its experimental daily weight loss pill, danuglipron, after a trial patient showed signs of potential liver injury.

Although the patient’s liver enzymes quickly returned to normal after stopping the drug, Pfizer halted the program after reviewing all clinical data and regulatory feedback.

This marks another setback in Pfizer’s attempt to enter the booming GLP-1 weight loss drug market, currently led by Eli Lilly and Novo Nordisk, CNBC has reported.

Despite this, Pfizer continues to develop other obesity drugs, including an oral GIPR blocker and another once-daily GLP-1 pill in early trials.

read more: https://www.cnbc.com/2025/04/14/pfizer-scraps-daily-weight-loss-pill-danuglipron.html

👍 Like this video to raise awareness about the risks and challenges in developing new weight loss medications.

💬 Comment below—do you think pharmaceutical companies are moving too fast in the race for obesity drugs?

🔗 Share this video to keep others informed about the latest developments in the weight loss drug industry.

💊 Want to support the channel? Hit the YouTube Thanks button—your support helps us bring more updates on health innovation and pharmaceutical breakthroughs.

👉 Don’t forget to subscribe for more coverage on drug trials, public health, and the business of medicine.

Thanks for watching and supporting the channel. Let’s stay informed about what’s really behind the latest health trends. 🧬📉🩺

Links for B.C.

Visit My Website
https://bcbegley.com

Follow Me On Facebook
https://www.facebook.com/B.C.Begley

Subscribe To My Patreon
https://www.patreon.com/bcbegley

Watch Me On YouTube
https://www.youtube.com/channel/UCGoUf-QQTlTN-BIh3ERCE9A

Follow Me On Twitter
https://twitter.com/BC_News1

Watch Me On Rumble
https://rumble.com/c/c-280191

Follow Me On Gab
https://gab.com/BC_Begley

Follow Me On Truth Social
https://truthsocial.com/@BC_Begley

Follow Me On BlueSky
https://bsky.app/profile/bcbegley.bsky.social

Watch Me On TikTok
https://www.tiktok.com/@bcbegley

#Pfizer #WeightLossDrugs #GLP1